BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27694951)

  • 1. Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis.
    Tan DW; Fu Y; Su Q; Guan MJ; Kong P; Wang SQ; Wang HL
    Sci Rep; 2016 Oct; 6():33789. PubMed ID: 27694951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
    Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma.
    Buettner S; Spolverato G; Kimbrough CW; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Koerkamp BG; Pawlik TM
    Surgery; 2018 Sep; 164(3):411-418. PubMed ID: 29903509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.
    Beal EW; Wei L; Ethun CG; Black SM; Dillhoff M; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Pawlik TM; Scoggins C; Martin RC; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR
    HPB (Oxford); 2016 Nov; 18(11):950-957. PubMed ID: 27683047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
    Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
    World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease.
    Sellers CM; Uhlig J; Ludwig JM; Stein SM; Kim HS
    Cancer Med; 2019 Oct; 8(13):5916-5929. PubMed ID: 31429524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma.
    Lin G; Liu Y; Li S; Mao Y; Wang J; Shuang Z; Chen J; Li S
    Oncotarget; 2016 Aug; 7(32):50963-50971. PubMed ID: 26918355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.
    Chen Q; Yang LX; Li XD; Yin D; Shi SM; Chen EB; Yu L; Zhou ZJ; Zhou SL; Shi YH; Fan J; Zhou J; Dai Z
    Tumour Biol; 2015 Jul; 36(7):5283-9. PubMed ID: 25672606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma.
    Omichi K; Cloyd JM; Yamashita S; Tzeng CD; Conrad C; Chun YS; Aloia TA; Vauthey JN
    Surgery; 2017 Oct; 162(4):752-765. PubMed ID: 28688518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Biomarker-Based Preoperative Prognostic Grading System for Predicting Survival After Surgery for Intrahepatic Cholangiocarcinoma.
    Yoh T; Seo S; Hatano E; Taura K; Fuji H; Ikeno Y; Okuda Y; Yasuchika K; Kaido T; Okajima H; Uemoto S
    Ann Surg Oncol; 2017 May; 24(5):1351-1357. PubMed ID: 28108828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
    Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
    Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: A meta-analysis.
    Li H; Zhao Y; Zheng F
    Medicine (Baltimore); 2019 Jan; 98(3):e14126. PubMed ID: 30653142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review.
    Wu J; Chen M; Liang C; Su W
    Oncotarget; 2017 Feb; 8(8):13400-13412. PubMed ID: 28077792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.
    Gu XB; Tian T; Tian XJ; Zhang XJ
    Sci Rep; 2015 Jul; 5():12493. PubMed ID: 26205001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy.
    Ha H; Nam AR; Bang JH; Park JE; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY
    Oncotarget; 2016 Nov; 7(47):76604-76612. PubMed ID: 27780932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy.
    Lee BS; Lee SH; Son JH; Jang DK; Chung KH; Lee YS; Paik WH; Ryu JK; Kim YT
    Cancer Immunol Immunother; 2016 Feb; 65(2):141-50. PubMed ID: 26728479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer.
    Choi WJ; Cleghorn MC; Jiang H; Jackson TD; Okrainec A; Quereshy FA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S603-13. PubMed ID: 25900206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis.
    Li MX; Liu XM; Zhang XF; Zhang JF; Wang WL; Zhu Y; Dong J; Cheng JW; Liu ZW; Ma L; Lv Y
    Int J Cancer; 2014 May; 134(10):2403-13. PubMed ID: 24122750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.